INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2022) III. Quarter |
(Jun 30 2022) II. Quarter |
(Mar 31 2022) I. Quarter |
(Dec 31 2021) IV. Quarter |
(Sep 30 2021) III. Quarter |
Dividend Income, Operating |
- |
- |
- |
|
0.02 |
Equity Securities Fv Ni Unrealized Gain Loss |
- |
- |
- |
|
- |
Conversion Fees |
- |
- |
- |
|
- |
Interest Income Loans Held In Portfolio |
1.74 |
0.52 |
- |
|
- |
Fee Income Loans Held In Portfolio |
0.17 |
0.01 |
- |
|
- |
Other Revenue |
0.00 |
- |
- |
|
- |
Total Revenue |
1.91 |
0.53 |
0.00 |
-5.72 |
0.02 |
Direct Costs of Leased and Rented Property or Equipment |
- |
- |
- |
- |
- |
Gross
Profit |
1.91 |
0.53 |
0.00 |
-5.72 |
0.02 |
Selling, Administration, Marketing |
1.57 |
1.56 |
0.73 |
0.68 |
0.59 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research & development |
- |
- |
- |
- |
- |
Business Combination, Acquisition Related Costs |
- |
0.09 |
0.42 |
3.91 |
- |
Other operatinig exp. /-income |
1.57 |
1.01 |
0.92 |
- |
0.00 |
Legal Fees |
0.80 |
1.38 |
1.36 |
6.89 |
- |
Salaries And Employee Benefits |
- |
- |
- |
1.56 |
0.88 |
Fees and Commission |
0.26 |
0.31 |
0.27 |
-6.73 |
3.73 |
Total operating costs including COS |
4.19 |
4.34 |
3.70 |
6.30 |
5.19 |
Operating income/-loss
|
-2.29 |
-3.81 |
-3.70 |
-12.02 |
-5.17 |
Other Deductions / - Income |
Interest expense |
0.44 |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
0.44 |
- |
- |
- |
- |
Gain (Loss) on Sales of Loans, Net |
-1.56 |
- |
- |
- |
- |
Foreign Currency Transaction Gain (Loss), before Tax |
- |
- |
0.00 |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
2.58 |
0.32 |
-0.01 |
-5.73 |
1.32 |
Direct Loan Expense |
0.10 |
- |
- |
- |
- |
Total costs & expenses |
5.75 |
4.66 |
3.69 |
0.57 |
6.50 |
Income /-loss before income taxes |
-3.84 |
-4.13 |
-3.69 |
-6.29 |
-6.48 |
Income taxes expenses/-benefit |
0.15 |
0.01 |
0.01 |
2.10 |
-0.79 |
Income after income taxes |
-3.99 |
-4.13 |
-3.70 |
-8.39 |
-5.70 |
Net income/-loss
of other equity |
0.00 |
- |
- |
0.00 |
0.00 |
Income/-loss
from cont. Ops. |
-3.99 |
-4.13 |
-3.70 |
-8.39 |
-5.70 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-3.99 |
-4.13 |
-3.70 |
-8.39 |
-5.70 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-3.99 |
-4.13 |
-3.70 |
-8.39 |
-5.70 |
EBIT |
-3.41 |
-4.13 |
-3.69 |
-6.29 |
-6.48 |
EBITD |
-3.37 |
-4.05 |
-3.62 |
-6.22 |
-6.41 |
EBITDA |
-3.37 |
-4.05 |
-3.62 |
-6.22 |
-6.41 |